Generic Esketamine vs Spravato: Cost and Availability

As of 2026, there is no FDA-approved generic version of esketamine nasal spray. Spravato (esketamine) is still the only branded esketamine product on the U.S. market, and its patent protections mean a true generic is not yet available at the pharmacy counter. So when people search for "generic esketamine nasal spray cost vs Spravato," the honest answer is that the comparison is mostly theoretical for now — but there are real, lower-cost alternatives worth understanding, especially compounded and generic racemic ketamine, which is a different but related medication.

Generic Esketamine Nasal Spray Cost vs Spravato: What Actually Exists

Esketamine is the "S" half of the ketamine molecule, and Spravato is its only branded form. Because no generic esketamine nasal spray has been approved, you cannot currently compare a brand price to a generic price the way you might with, say, a blood-pressure drug. What does exist is generic racemic ketamine — the original, decades-old anesthetic that contains both the S and R forms. Generic ketamine is widely available as an inexpensive injectable and is used off-label for depression by many clinics and telehealth providers, often as oral lozenges or IV infusions rather than a nasal spray.

This distinction matters for cost. Spravato carries a high per-dose price as a branded specialty drug administered under medical supervision. Generic ketamine, by contrast, is a low-cost compound, though the service around it (clinician time, monitoring, IV setup) is what you actually pay for.

How Spravato Pricing and Coverage Work

Spravato is dispensed through a restricted FDA program called a REMS, meaning it can only be given in a certified healthcare setting where you are monitored for at least two hours afterward. Your total cost typically has two parts:

• The medication itself, billed as a specialty drug — often the largest line item before insurance.
• The in-office administration and monitoring fee, billed by the clinic.

The encouraging news for patients is that Spravato is FDA-approved for treatment-resistant depression and depressive symptoms in adults with major depressive disorder who have suicidal thoughts or behavior. Because it is FDA-approved, many commercial insurers and Medicare cover it, frequently with prior authorization. The manufacturer also offers patient savings and copay-assistance programs that can substantially reduce out-of-pocket costs for eligible, commercially insured patients. Always confirm your specific plan's benefits before starting.

Generic Ketamine: The Lower-Cost Alternative People Are Really Asking About

When budget is the concern, generic racemic ketamine is usually the more relevant comparison. It is delivered as IV infusions, intramuscular injections, or compounded oral or sublingual lozenges — the latter being common in at-home telehealth programs. These routes are used off-label, meaning the FDA has not approved ketamine specifically for depression even though it is approved as an anesthetic.

The off-label status is the key trade-off:

• Lower drug cost because generic ketamine is cheap to produce.
• Less consistent insurance coverage, since insurers often decline off-label uses; many patients pay out of pocket.
• More route options, including at-home lozenges that avoid clinic facility fees.

Spravato vs Generic Ketamine at a Glance

Factor	Spravato (esketamine)	Generic ketamine (racemic)
FDA approval for depression	Yes (specific indications)	No — used off-label
Generic available?	No	Yes (injectable/compounded)
Typical insurance coverage	Often covered, prior auth common	Often not covered; cash-pay common
Where given	Certified clinic (REMS), monitored	Clinic IV/IM or at-home lozenges
Main cost driver	Branded drug price	Clinician time and monitoring

Which Path Tends to Cost Less?

There is no universal answer, because the math depends heavily on your insurance. If you have commercial coverage that approves Spravato and you qualify for copay assistance, Spravato can sometimes cost less out of pocket than a cash-pay generic ketamine program. If you are uninsured or your plan denies coverage, generic ketamine — particularly at-home lozenge programs — is often the more affordable route. Studies suggest both esketamine and racemic ketamine can produce rapid improvements in depression for some patients, but they are not interchangeable, and effectiveness varies by individual.

Because the variables stack up quickly, it helps to compare total expected cost across a full treatment course rather than per dose. Our cost and insurance guide walks through how to estimate this, and our comparisons hub breaks down other ketamine-versus-ketamine questions side by side.

Questions to Ask Before You Commit

1. Will my insurance cover Spravato, and what is the prior-authorization process?
2. Do I qualify for the manufacturer's copay or patient-assistance program?
3. For generic ketamine, is the quoted price cash-pay only, and what does it include?
4. Is this medication appropriate for my diagnosis and medical history?

A prescribing clinician can help you weigh safety, suitability, and cost together. If you are still selecting a provider, our guidance on choosing a provider covers what credentials and monitoring practices to look for.

This article is patient education, not medical advice. Treatment decisions, dosing, and cost details should be confirmed with a licensed clinician and your insurer, as availability and pricing change over time.

Frequently Asked Questions

Is there a generic version of Spravato?

No. As of 2026, the FDA has not approved a generic esketamine nasal spray, so Spravato remains the only branded esketamine product. Generic racemic ketamine exists, but it is a related, different medication used off-label.

What is the difference between esketamine and generic ketamine?

Esketamine (Spravato) is the isolated S-form of the molecule, FDA-approved for certain depression indications. Generic ketamine is the racemic mix of both S and R forms, approved as an anesthetic and used off-label for depression.

Does insurance cover Spravato or generic ketamine?

Because Spravato is FDA-approved for depression, many insurers cover it, often with prior authorization. Generic ketamine for depression is off-label, so it is frequently not covered and paid out of pocket. Always verify your specific plan.

Which is cheaper, Spravato or generic ketamine?

It depends on your coverage. With insurance approval and copay assistance, Spravato may cost less out of pocket. Without coverage, cash-pay generic ketamine, especially at-home lozenges, is often more affordable.